Sunshine Biopharma (SBFM) Cash from Investing Activities Growth (3y) (2018 - 2026)
Sunshine Biopharma (SBFM) Cash from Investing Activities Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -53.63% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -55.36% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 34.35% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 33.61% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 15.92% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -2.45% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -36.76% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.52 Mn | -12.23 Mn | 2.43 Mn | 72.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.98% |
| Mar 31, 2026 | 10.61% |
| Dec 31, 2025 | 84.91% |
| Dec 31, 2023 | -783.04% |
| Sep 30, 2023 | 194.62% |
| Dec 31, 2022 | -2,471.25% |
| Dec 31, 2020 | 83.30% |
| Sep 30, 2020 | -26.74% |
| Dec 31, 2019 | 7.76% |
| Jun 30, 2019 | -76.93% |
| Dec 31, 2018 | 26.28% |